Systematic review of the mechanism and assessment of liver fibrosis in biliary atresia
Topic overview
This systematic review examines mechanisms driving liver fibrosis in biliary atresia (BA) and proposes a new grading system for assessing disease severity. The authors highlight TGF-β1 signaling as the critical pathway and identify epithelial-mesenchymal transition as a key area requiring further investigation to improve prognostic accuracy and treatment guidance in pediatric BA patients.
Key takeaways
- TGF-β1 signaling pathway is identified as the most critical mechanism driving liver fibrosis progression in biliary atresia patients.
- A novel grading system for BA liver fibrosis may improve prognostic assessment and guide treatment decisions more accurately than existing methods.
- Epithelial-mesenchymal transition (EMT) in BA remains controversial and requires further investigation to clarify its role in fibrosis.
- Systematic review of 58 studies identified 25 mechanism-focused and 5 assessment-focused articles on BA liver fibrosis from a single research team.
- Better understanding of fibrosis mechanisms in BA could lead to targeted therapies to slow disease progression post-Kasai procedure.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Systematic review of the mechanism and assessment of liver fibrosis in biliary atresia. GlobalCastMD Medical Library. 2024-07-20. https://dev.library.globalcastmd.com/article/8904?via_space=staycurrentmd
Comments